Site search2015
- 2015.11.13IRFinancial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016 [Japanese GAAP] (non-consolidated)（162KB）
- 2015.11.4IRGreenPeptide Receives Clearance from FDA to Proceed with Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine GRN-1201（126KB）
- 2015.10.6NewsGreenPeptide Announces Filing of Investigational New Drug for a Phase 1 Clinical Trial of a Novel Cancer Peptide Vaccine GRN-1201
- 2015.7.6NewsNotification Regarding the Progress of Phase III Clinical Trials of Cancer Peptide Vaccine ITK-1 in Patients with Castration-Resistant Prostate Cancer
- 2015.6.29NewsAnnouncement of Management Changes
- 2015.10.6NewsGreenPeptide Announces Filing of Investigational New Drug for a Phase 1 Clinical Trial of a Novel Cancer Peptide Vaccine GRN-1201
- 2015.7.6NewsNotification Regarding the Progress of Phase III Clinical Trials of Cancer Peptide Vaccine ITK-1 in Patients with Castration-Resistant Prostate Cancer
- 2015.6.29NewsAnnouncement of Management Changes